Suppr超能文献

采用口服脉冲式特比萘芬治疗犬小孢子菌所致头癣。

Treatment of Microsporum spp. tinea capitis with pulsed oral terbinafine.

作者信息

Ungpakorn R, Ayutyanont T, Reangchainam S, Supanya S

机构信息

Institute of Dermatology, Bangkok, Thailand.

出版信息

Clin Exp Dermatol. 2004 May;29(3):300-3. doi: 10.1111/j.1365-2230.2004.01493.x.

Abstract

Oral terbinafine is widely used in the treatment of superficial dermatomycoses as well as subcutaneous and systemic mycoses. It is also useful in treating tinea capitis, although for Microsporum canis and some ectothrix organisms, the effectiveness of the drug may be less than for some endothrix infections. In this study, we undertook a double-blind randomized trial comparing standard and double doses of terbinafine given in a pulsed protocol (1 week on, 3 weeks off) in treating Microsporum spp. tinea capitis in 42 individuals. We found that pulsed terbinafine at a higher dose did not improve treatment efficacy. However, our data clearly demonstrated that the duration of treatment is an important factor in determining clinical outcome and cure. Two pulses of standard dose terbinafine were found to be sufficient for treating most cases of Microsporum spp. tinea capitis, although additional treatment (a third pulse) may be needed if clinical improvement is not evident at 8 weeks after initiating therapy.

摘要

口服特比萘芬广泛用于治疗浅表皮肤真菌病以及皮下和全身性真菌病。它在治疗头癣方面也很有用,尽管对于犬小孢子菌和一些毛外癣菌,该药物的有效性可能低于某些毛内癣菌感染。在本研究中,我们进行了一项双盲随机试验,比较了按脉冲方案(用药1周,停药3周)给予标准剂量和双倍剂量特比萘芬治疗42例小孢子菌属头癣的效果。我们发现,高剂量脉冲式特比萘芬并未提高治疗效果。然而,我们的数据清楚地表明,治疗持续时间是决定临床结果和治愈情况的一个重要因素。发现两脉冲标准剂量的特比萘芬足以治疗大多数小孢子菌属头癣病例,不过,如果在开始治疗8周后临床改善不明显,可能需要额外治疗(第三个脉冲)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验